IL149141A0 - Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same - Google Patents

Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same

Info

Publication number
IL149141A0
IL149141A0 IL14914100A IL14914100A IL149141A0 IL 149141 A0 IL149141 A0 IL 149141A0 IL 14914100 A IL14914100 A IL 14914100A IL 14914100 A IL14914100 A IL 14914100A IL 149141 A0 IL149141 A0 IL 149141A0
Authority
IL
Israel
Prior art keywords
oestrogen
progesterone
producing
same
medicament based
Prior art date
Application number
IL14914100A
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL149141(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of IL149141A0 publication Critical patent/IL149141A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
IL14914100A 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same IL149141A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002587 WO2001030355A1 (en) 1999-10-25 1999-10-25 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
PCT/FR2000/002952 WO2001030358A1 (en) 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same

Publications (1)

Publication Number Publication Date
IL149141A0 true IL149141A0 (en) 2002-11-10

Family

ID=9542725

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14914100A IL149141A0 (en) 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same
IL149141A IL149141A (en) 1999-10-25 2002-04-15 Contraceptive medicament based on a progesterone and an oestrogen

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149141A IL149141A (en) 1999-10-25 2002-04-15 Contraceptive medicament based on a progesterone and an oestrogen

Country Status (21)

Country Link
EP (2) EP1227815A1 (en)
JP (1) JP5484646B2 (en)
KR (1) KR100549625B1 (en)
CN (1) CN1205936C (en)
AP (1) AP1707A (en)
AU (1) AU784478B2 (en)
BR (1) BR0014952A (en)
CA (1) CA2388857C (en)
CR (1) CR6627A (en)
CZ (1) CZ301982B6 (en)
ES (1) ES2565688T3 (en)
HK (2) HK1048600A1 (en)
HU (1) HU230467B1 (en)
IL (2) IL149141A0 (en)
MX (1) MXPA02004083A (en)
NO (1) NO330885B1 (en)
NZ (1) NZ518308A (en)
OA (1) OA12071A (en)
RU (1) RU2258512C2 (en)
WO (2) WO2001030355A1 (en)
ZA (1) ZA200203399B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (en) 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
WO2001030356A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
FR2814074B1 (en) * 2000-09-15 2003-03-07 Theramex NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
KR100975350B1 (en) * 2002-11-29 2010-08-12 재단법인서울대학교산학협력재단 Transgenic cloned cow producing human lactoferricin and method for producing the same
MXPA06014579A (en) * 2004-07-07 2007-03-01 Wyeth Corp Cyclic progestin regimens and kits.
ATE543489T1 (en) * 2005-05-26 2012-02-15 Teva Womens Health Inc ORAL DOSAGE FORMS CONTAINING PROGESTERONE AND METHODS OF USE AND MANUFACTURING THEREOF
CN103877059A (en) * 2014-03-26 2014-06-25 邵娜 Nomegestrol acetate tablet and preparation process thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (en) 1986-07-15 2003-10-06 Wyeth Corp Use of a composition comprising an estrogen and a progestogen for the preparation of a dosage form to provide hormone replacement therapy and contraception for women during the premenopause and pack to provide the composition
NO301689B1 (en) 1987-09-24 1997-12-01 Jencap Research Ltd Contraceptive preparation in the form of a package
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5532416A (en) 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE4344462C2 (en) 1993-12-22 1996-02-01 Schering Ag Composition for contraception
FR2737411B1 (en) * 1995-08-01 1997-10-17 Theramex NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES
DE19529767A1 (en) 1995-08-12 1997-02-13 Huels Chemische Werke Ag Amphiphilic compounds with several hydrophilic and hydrophobic groups based on amino succinic acid derivatives
US5902914A (en) 1995-08-14 1999-05-11 Alliedsignal Inc. Process for the preparation of halogenated alkanes
AUPN479995A0 (en) 1995-08-15 1995-09-07 Leon Kruss Technology Pty Limited Lightweight cementitious composition
US5654494A (en) 1995-08-18 1997-08-05 Alliedsignal Inc. Process for the manufacture of 1,1,1,2-tetrafluoroethane
US5530167A (en) 1995-08-21 1996-06-25 Eastman Chemical Company Process for the preparation of 1,4-butenediol
DE19536744A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade with interchangeable wiper rubber for a vehicle wiper
DE19536745A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle, in particular a motor vehicle
DE29515703U1 (en) 1995-10-02 1996-02-08 Föhl, Artur, 73614 Schorndorf Rotary drive device for a belt tensioner
JP3616966B2 (en) 1995-10-02 2005-02-02 エヌエスケー・オートリブ株式会社 Seat belt retractor
DE19536742A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle
EP0770338B1 (en) 1995-10-23 2002-09-25 Honda Access Corp. Cap body of a helmet
DE19540253C2 (en) 1995-10-28 1998-06-04 Jenapharm Gmbh Multi-phase preparation for contraception based on natural estrogens
DE19549264A1 (en) 1995-12-23 1997-06-26 Schering Ag Contraception procedure and kit
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
FR2754179B1 (en) * 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
GB9621990D0 (en) 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19705229C2 (en) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
PT1007052E (en) 1997-08-27 2005-01-31 Ortho Mcneil Pharm Inc COMBINATIONS OF PROGESTINES OF ENDOMETRICAL GROWTH AND PROGESTINES OF ATROPIA OF ENDOMETRIAL WITH ESTROGENES IN ORAL CONTRACEPTION
DE19739916C2 (en) 1997-09-11 2001-09-13 Hesch Rolf Dieter Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
CA2301162A1 (en) 1997-09-12 1999-03-25 Michael Jay Gast Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin

Also Published As

Publication number Publication date
HK1048600A1 (en) 2003-04-11
EP2020236A1 (en) 2009-02-04
AP1707A (en) 2007-02-26
HK1129564A1 (en) 2009-12-04
CN1382054A (en) 2002-11-27
CN1205936C (en) 2005-06-15
NZ518308A (en) 2006-01-27
KR20020073333A (en) 2002-09-23
ZA200203399B (en) 2004-02-09
OA12071A (en) 2006-05-04
NO20021948D0 (en) 2002-04-25
EP2020236B1 (en) 2016-01-27
HUP0203443A2 (en) 2003-01-28
CZ20021426A3 (en) 2002-08-14
CR6627A (en) 2008-06-18
AU784478B2 (en) 2006-04-13
EP1227815A1 (en) 2002-08-07
RU2002113654A (en) 2004-01-27
MXPA02004083A (en) 2003-08-20
JP2003518013A (en) 2003-06-03
RU2258512C2 (en) 2005-08-20
PL354518A1 (en) 2004-01-26
HU230467B1 (en) 2016-07-28
HUP0203443A3 (en) 2003-12-29
AU1033501A (en) 2001-05-08
NO330885B1 (en) 2011-08-08
NO20021948L (en) 2002-06-25
IL149141A (en) 2008-06-05
BR0014952A (en) 2003-07-29
CA2388857A1 (en) 2001-05-03
KR100549625B1 (en) 2006-02-08
AP2002002485A0 (en) 2002-06-30
CA2388857C (en) 2011-06-07
WO2001030355A1 (en) 2001-05-03
JP5484646B2 (en) 2014-05-07
ES2565688T3 (en) 2016-04-06
WO2001030358A1 (en) 2001-05-03
CZ301982B6 (en) 2010-08-25

Similar Documents

Publication Publication Date Title
HUP0104037A3 (en) Drug delivery device, especially for the delivery of progestins and estrogens
AU1176199A (en) Aligner, exposure method and device manufacturing method
IL154521A0 (en) Contraception process and administration form for the same
AU2671200A (en) Method and device for producing a metallic honeycomb body
AU2325900A (en) Exposure device, exposure method, and device manufacturing method
HK1041557A1 (en) An integrated circuit and method for preparation thereof.
HK1129564A1 (en) Method of contraception based on a progestative and oestrogen
AU7667500A (en) Method and device for atomic interferometry nanolithography
MXPA02002069A (en) Apparatus and method for anesthetizing the cervical region of a female.
AU6565800A (en) Method and device for producing moulded parts
AP2002002475A0 (en) Hormonal composition based on a progesterone and an oestrogen and use thereof
PL346834A1 (en) Method and device for producing a van body, and van body thus produced
AU1678292A (en) A device in a stoma bandage, a method in using said device, and a method for producing the device
HK1045950A1 (en) An oral aqueous solution of prucalopride and a method for producing the same.
SG90155A1 (en) A semiconductor device and a process for producing the same
AU1687999A (en) Exposure method and scanning-type aligner
ZA200110459B (en) Method and device for producing pellets.
EP1126478A4 (en) Ptc device and method for producing the same
GB2366169B (en) A method and an arrangement for preventing metastability
HUP0303553A3 (en) Plaster which contains steroids, and a method for the production and use thereof
AU5303499A (en) Method and device for producing mask
EP1167409A4 (en) Polyacetal copolymer and method for producing the same
AU1152800A (en) Orally applicable therapeutic dosage form which spontaneously disintegrates uponcontact with a liquid and method for producing the same
AU6847600A (en) Canal filling method and device for providing the filling product
AU6333000A (en) Method for correcting the figure of a person and for developing an acquired correct-position reflex as well as the figure, and mini-trainer "tonus-training" forrealising the same

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted